01
Discover
Declared and suspected AI use across clinical, admin, marketing and operational workflows.
FREE WEBSITE SCREENING TOOL
A preliminary check: could your clinic show its AI use is governed and evidenced?
This is a free website screening resource, not an ELSA AI paid service, product or engagement. Private GP, dental and specialist clinics are already using ambient scribes, ChatGPT, Copilot, transcription tools and AI-enabled platforms. Answer a few questions about one AI use case to get an advisory signal on whether it looks lower priority, control-dependent or in need of priority governance review.
Free website screening resource only. Not an ELSA AI paid service, product or engagement. This tool provides an advisory governance risk indicator only.
Designed for one AI use case at a time
No patient data required
Around 2 minutes
Advisory indicator only
Built for private healthcare providers
Private GP clinicsDental practicesSpecialist clinicsAmbient scribe teams
Why this matters
The risk is not AI use. The risk is having no documented position.
Most organisations do not start with a clean AI programme. They start with informal adoption: an ambient scribe in consultation, ChatGPT for drafting, Copilot for admin, transcription tools in meetings, and AI-enabled platforms introduced by suppliers. The governance risk is having no documented position when a patient, DPO, insurer, MDO, CQC inspector, commissioner or board asks how that AI use is controlled.
Interactive check
Your AI Governance Exposure Signal
This free website screening tool is not the Clinical AI Exposure Diagnostic™ or any other ELSA AI paid engagement. Select the option that best reflects one AI use case in your clinic or group, for example an ambient scribe, ChatGPT or Copilot use, AI transcription, imaging AI, patient messaging automation or admin workflow automation.
Boundary
What this screening check cannot show you
A short online screening check cannot discover shadow AI, inspect vendor contracts, confirm DPIA status, review patient transparency wording or evidence how clinicians are using tools in practice. That requires the paid Clinical AI Exposure Diagnostic™ engagement with ELSA AI.
02
Evidence
DPIA readiness, vendor data position, human oversight, patient transparency and clinical safety indicators.
03
Decide
A board-readable RAG exposure map and 30-day priority action plan.
04
Govern
A pathway into policy, register, risk register, staff guidance, patient wording and evidence pack.
Clinical AI Exposure Diagnostic™
Need more than a screening signal?
The paid Clinical AI Exposure Diagnostic™ is a separate ELSA AI engagement. In four working days from completed intake, it gives your clinic or group a documented view of what AI is in use, what patient data may be involved, what evidence is missing and what should be prioritised next.
Clinical AI Exposure Diagnostic™: £5,500 + VAT for the published Standard Diagnostic scope. If an ambient scribe is in use, in trial or planned, the engagement routes to the Ambient scribe assessment, from £8,500 + VAT and delivered in six working days.